StockData
Protara Therapeutics, Inc. logo

Protara Therapeutics, Inc. (TARA) stock

TARANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$2.34+0.02 (+0.86%)

Close on Nov 18, 2026Market cap $138.28MP/E –Yield –

Protara Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2014 it was $2.95M.

Annual revenue

PeriodPeriod endValueChange
FY2014Dec 31, 2014$2.95M–

More Protara Therapeutics figures

See a number that looks wrong?